Gastrokine 1 regulates NF-κB signaling pathway and cytokine expression in gastric cancers

Journal of Cellular Biochemistry

Volumn 114, Issue 8, 2013, Pages 1800-1809

  Yoon, Jung Hwan ^a   La Cho, Mi ^a   Choi, Yoo Jin ^a   Back, Ji Yeon ^b   Park, Mi Kyung ^a   Lee, Suk Woo ^a   Choi, Byung Joon ^a   Ashktorab, Hassan ^c   Smoot, Duane T ^c   Nam, Suk Woo ^a   Lee, Jung Young ^a   Park, Won Sang ^a  

^a The Catholic University of Korea   (South Korea)

^b National Cancer Center   (South Korea)

^c HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

CYTOKINE; GASTRIC CANCER; GKN1; INFLAMMATORY MEDIATOR; NF B

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; GASTROKINE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 6; INTERLEUKIN 8; UNCLASSIFIED DRUG;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; LYMPHOCYTE MIGRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH CANCER; TUMOR IMMUNITY;

CYCLOOXYGENASE 2; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; JURKAT CELLS; MALE; NEOPLASM PROTEINS; NF-KAPPA B; PEPTIDE HORMONES; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 84879162691     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24524     Document Type: Article

References (37)

1. Basso D, Scrigner M, Toma A, Navaglia F, Di Mario F, Rugge M, Plebani M,. 1996. Helicobacter pylori infection enhances mucosal interleukin-1β, interleukin-6, and the soluble receptor of interleukin-2. Int J Clin Lab Res 26: 207-210.
2. Braun DA, Fribourg M, Sealfon SC,. 2013. Cytokine response is determined by duration of receptor and STAT3 activation. J Biol Chem 288: 2986-2993.
3. Chung HS, Lee JH, Kim H, Lee HJ, Kim SH, Kwon HK, Im SH, Bae H,. 2010. Foxp3 is a novel repressor of microglia activation. Glia 58: 1247-1256.
4. Grant C, Oh U, Fugo K, Takenouchi N, Griffith C, Yao K, Newhook TE, Ratner L, Jacobson S,. 2006. Foxp3 represses retroviral transcription by targeting both NF-kappaB and CREB pathways. PLoS Pathog 2: e33.
5. Guang W, Ding H, Czinn SJ, Kim KC, Blanchard TG, Lillehoj EP,. 2010. Muc1 cell surface mucin attenuates epithelial inflammation in response to a common mucosal pathogen. J Biol Chem 285: 20547-20557.
6. Heo YJ, Joo YB, Oh HJ, Park MK, Heo YM, Cho ML, Kwok SK, Ju JH, Park KS, Cho SG, Park SH, Kim HY, Min JK,. 2010. IL-10 suppresses Th17 cells and promotes regulatory T cells in the CD4+ T cell population of rheumatoid arthritis patients. Immunol Lett 127: 150-156.
7. Holck S, Nørgaard A, Bennedsen M, Permin H, Norn S, Andersen LP,. 2003. Gastric mucosal cytokine responses in Helicobacter pylori-infected patients with gastritis and peptic ulcers. Association with inflammatory parameters and bacteria load. FEMS Immunol Med Microbiol 36: 175-180.
8. Ikeguchi M, Hatada T, Yamamoto M, Miyake T, Matsunaga T, Miyake T, Fukumoto Y, Yamada Y, Fukuda K, Saito H, Tatebe S,. 2009. Serum interleukin-6 and -10 levels in patients with gastric cancer. Gastric cancer 12: 95-100.
9. Isomoto H, Mizuta Y, Miyazaki M, Takeshima F, Omagari K, Murae K, Nishiyama T, Inoue K, Murata I, Kohno S,. 2000. Implication of NF-kappaB in Helicobacter pylori-associated gastritis. Am J Gastroenterol 95: 2768-2776.
10. Kabir S,. 2011. The role of interleukin-17 in the Helicobacter pylori induced infection and immunity. Helicobacter 16: 1-8.
11. Kang MJ, Ryu BK, Lee MG, Han J, Lee JH, Ha Tk, Byun DS, Chae KS, Lee BH, Chun HS, Lee KY, Kim HJ, Chi SG,. 2008. NF-kappaB activates transcription of the RNA-binding factor HuR, via PI3K-AKT signaling to promote gastric tumorigenesis. Gastroenterology 135: 2030-2042.
12. Kennedy CL, Najdovska M, Jones GW, McLeod L, Hughes NR, Allison C, Ooi CH, Tan P, Ferrero RL, Jones SA, Dev A, Sievert W, Bhathal PS, Jenkins BJ,. 2011. The molecular pathogenesis of STAT3-driven gastric tumourigenesis in mice is independent of IL-17. J Pathol 225: 255-264.
13. Koki AT, Masferrer JL,. 2002. Celecoxib: A specific COX-2 inhibitor with anticancer properties. Cancer Control 9: 28-35.
14. Li GQ, Xia HH, Chen MH, Gu Q, Wang JD, Peng JZ, Chan AO, Cho CH, So HL, Lam SK, Hu PH, Liang YJ, Lin HL, Berg DE, Feng ZH, Langenbach R, Wong BC,. 2006. Effects of cyclooxygenase-1 and -2 gene disruption on Helicobacter pylori-induced gastric inflammation. J Infect Dis 193: 1037-1046.
15. Liao WC, Lin JT, Wu CY, Huang SP, Lin MT, Wu AS, Huang YJ, Wu MS,. 2008. Serum interleukin-6 level but genotype predicts survival after resection in stages II and III gastric carcinoma. Clin Cancer Res 14: 428-434.
16. Lim JW, Kim H, Kim KH,. 2001. Nuclear factor-kappaB regulates cylooxygenase-2 expression and cell proliferation in human gastric cancer cells. Lab Invest 81: 349-360.
17. Lin MT, Lin BR, Chang CC, Chu CY, Su HJ, Chen ST, Jeng YM, Kuo ML,. 2007. IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/RhoA/ROCK signaling pathway. Int J Cancer 120: 2600-2608.
18. Lindholm C, Quiding-Järbrink M, Lönroth H, Hamlet A, Svennerholm AM,. 1998. Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun 66: 5964-5971.
19. Liu CA, Wang MJ, Chi CW, Wu CW, Chen JY,. 2004. Rho/Rhotekin-mediated NF-kappaB activation confers resistance to apoptosis. Oncogene 23: 8731-8742.
20. Luzza F, Parrello T, Monteleone G, Sebkova L, Romano M, Zarrilli R, Imeneo M, Pallone F,. 2000. Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa. J Immunol 165: 5332-5337.
21. Martin TE, Powell CT, Wang Z, Bhattacharyya S, Walsh-Reitz MM, Agarwal K, Toback FG,. 2003. A novel mitogenic protein that is highly expressed in cells of the gastric antrum mucosa. Am J Physiol Gastrointest Liver Physiol 285: G332-G343.
22. Matsumoto Y, Marusawa H, Kinoshita K, Endo Y, Kou T, Morisawa T, Azuma T, Okazaki IM, Honjo T, Chiba T,. 2007. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med 13: 470-476.
23. Nardone G, Rippa E, Martin G, Rocco A, Siciliano RA, Fiengo A, Cacace G, Malorni A, Budillon G, Arcari P,. 2007. Gastrokine 1 expression in patients with and without Helicobacter pylori infection. Dig Liver Dis 39: 122-129.
24. Oien KA, McGregor F, Butler S, Ferrier RK, Downie I, Bryce S, Burns S, Keith WN,. 2004. Gastrokine 1 is abundantly and specifically expressed in superficial gastric epithelium, down-regulated in gastric carcinoma, and shows high evolutionary conservation. J Pathol 203: 789-797.
25. Peek RM, Jr., Blaser MJ,. 2002. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2: 28-37.
26. Rippa E, La Monica G, Allocca R, Romano MF, De Palma M, Arcari P,. 2011. Overexpression of gastrokine 1 in gastric cancer cells induces Fas-mediated apoptosis. J Cell Physiol 226: 2571-2578.
27. Sharma SA, Tummuru MK, Blaser MJ, Kerr LD,. 1998. Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J Immunol 160: 2401-2407.
28. Shiozaki K, Nakamori S, Tsujie M, Okami J, Yamamoto H, Nagano H, Dono K, Umeshita K, Sakon M, Furukawa H, Hiratsuka M, Kasugai T, Ishiguro S, Monden M,. 2001. Human stomach-specific gene, CA11, is down-regulated in gastric cancer. Int J Oncol 19: 701-707.
29. Toback FG, Walsh-Reitz MM, Musch MW, Chang EB, Del Valle J, Ren H, Huang E, Martin TE,. 2003. Peptide fragments of AMP-18, a novel secreted gastric antrum mucosal protein, are mitogenic and motogenic. Am J Physiol Gastrointest Liver Physiol 285: G344-G353.
30. Walsh-Reitz MM, Huang EF, Musch MW, Chang EB, Martin TE, Kartha S, Toback FG,. 2005. AMP-18 protects barrier function of colonic epithelial cells: Role of tight junction proteins. Am J Physiol Gastrointest Liver Physiol 289: G163-G171.
31. Wang D, Dubois RN,. 2010. Eicosanoids and cancer. Nat Rev Cancer 10: 181-193.
32. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM,. 2006. Th17: An effect or CD4 T cell lineage with regulatory T cell ties. Immunity 24: 677-688.
33. Xing R, Li W, Cui J, Zhang J, Kang B, Wang Y, Wang Z, Liu S, Lu Y,. 2012. Gastrokine 1 induces senescence through p16/Rb pathway activation in gastric cancer cells. Gut 61: 43-52.
34. Yoon JH, Kang YH, Choi YJ, Park IS, Nam SW, Lee JY, Lee YS, Park WS,. 2011a. Gastrokine 1 functions as a tumor suppressor by inhibition of epithelial-mesenchymal transition in gastric cancers. J Cancer Res Clin Oncol 137: 1697-1704.
35. Yoon JH, Song JH, Zhang C, Jin M, Kang YH, Nam SW, Lee JY, Park WS,. 2011b. Inactivation of the gastrokine 1 gene in gastric adenomas and carcinomas. J Pathol 223: 618-625.
36. Yuasa Y,. 2003. Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev Cancer 3: 592-600.
37. Zhou Y, Toh ML, Zrioual S, Miossec P,. 2007. IL-17A versus IL-17F induced intracellular signal transduction pathways and modulation by IL-17RA and IL-17RC RNA interference in AGS gastric adenocarcinoma cells. Cytokine 38: 157-164.